Dalbavancin NDC 70069-830

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-830Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0830Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-830-01	70069083001	1 VIAL in 1 CARTON (70069-830-01) / 25 mL in 1 VIALMarketed from Jul 27, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dalbavancin
Generic name (nonproprietary): dalbavancin
Active ingredients: Dalbavancin hydrochloride — 500 mg/25mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Somerset Therapeutics, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219604
Marketing start: Jul 27, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Lipoglycopeptides (Chemical structure)
Identifiers: Product ID 70069-830_ed056e1e-9906-4daf-9895-a3cbcc017b09SPL ID ed056e1e-9906-4daf-9895-a3cbcc017b09SPL set ID f4c0bd0f-03c2-4ce5-bcc2-b58f21ce75c1RxCUI 1539243UNII 33WDQ7T81EUPC 0370069830017
Pharmacologic class: Lipoglycopeptide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069083001 followed by a unit qualifier and the quantity

Package 70069-0830-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

1 INDICATION AND USAGE Dalbavancin for injection is a lipoglycopeptide antibacterial indicated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. (1.1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of dalbavancin for injection and other antibacterial drugs, dalbavancin for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. (1.2) 1.1 Acute Bacterial Skin and Skin Structure Infections Dalbavancin for injection is indicated for the treat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219604

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219604
Product	Strength	Form · route	Labeler	Product NDC
Dalbavancin	Dalbavancin hydrochloride 500 mg/25mL	Injection, Powder, Lyophilized, For solutionIntravenous	BE Pharmaceuticals Inc.	71839-144